054 | CRISPR warnings, Tragically and medical cannabis, U of G genome researchers and more

by • June 13, 2017 • Feature, PodcastComments Off on 054 | CRISPR warnings, Tragically and medical cannabis, U of G genome researchers and more187

CRISPR genome editing could hold the key to treating and curing diseases such as cancer, leukemia, and HIV/AIDS. 


However, Dr. J. Keith Joung of Massachusetts General Hospital warns there is growing evidence that CRISPR could alter regions of the genome which researchers are not targeting. What are the consequences?The iconic Canadian rock band Tragically Hip is one of the latest investors in the country’s growing medical marijuana market.We’ve got these and more in this episode of the Biotechnology Podcast…Click on these links to read full stories:RESEARCHERS WARNED OF CRISPR OFF-TARGET EFFECTS

There’s a CRISPR genome editing boom of sorts going on with as many as 20 human trials being undertaken in several countries. However, researchers may be ignoring some serious drawback of the genome editing which made it easy and affordable for laboratories to target nearly any sequence.

 

 

 

 

THREE U OF G GETS GENOMICS RESEARCH GET $10.7-M SUPPORT

Prof Christine Baes

The Genome Canada’s Genomic Applications Partnership Program (GAPP) is chipping in $10.7 million to support three University of Guelph research projects in the area of genomic.

 

 

 

 

 

 TRAGICALLY HIP PARTNERS WITH ONTARIO CANNABIS PRODUCER

If you were ever in search any more indications that the local cannabis market is smoking, this just might be it.

The iconic Canadian rock band Tragically Hip is “happy to announce” that it has become partners with Newstrike Resources Ltd., which the group described a “Canada newest, soon to be public, a licensed producer of medicinal marijuana.”

Comments are closed.